Since epigenetic change is a reversible process and breast cancer patients with higher CGRRF1 had better survival, increasing the expression of CGRRF1 by altering the epigenetic modification might be a potential therapy that deserves future investigation. This evidence concerns the gene CGRRF1 and breast cancer.